Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| 1 |
Moderna
MRNA
|
$1.79B |
| 2 |
Illumina
ILMN
|
$780M |
| 3 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$727M |
| 4 |
NetEase
NTES
|
$692M |
| 5 |
DexCom
DXCM
|
$453M |
Top Sells
| 1 |
Tesla
TSLA
|
$5.22B |
| 2 |
Amazon
AMZN
|
$1.3B |
| 3 |
Alphabet (Google) Class C
GOOG
|
$610M |
| 4 |
Zillow
Z
|
$470M |
| 5 |
Ionis Pharmaceuticals
IONS
|
$271M |
Sector Composition
| 1 | Consumer Discretionary | 37.93% |
| 2 | Technology | 16.18% |
| 3 | Healthcare | 15.43% |
| 4 | Communication Services | 14.41% |
| 5 | Financials | 5.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Moody's
MCO
$91.4B
| $1.57B | 0.88% | 5,426,323 -107,846 | -2% | -$31.3M |
|
27
Intuitive Surgical
ISRG
$170B
| $1.56B | 0.87% | 1,910,477 +33,415 | +2% | +$27.3M |
|
28
Atlassian
TEAM
$46.6B
| $1.54B | 0.86% | 6,576,802 +78,271 | +1% | +$18.3M |
|
29
Microsoft
MSFT
$3.77T
| $1.53B | 0.85% | 6,860,324 -160,023 | -2% | -$35.6M |
|
30
Teladoc Health
TDOC
$1.37B
| $1.45B | 0.81% | 7,238,667 +996,628 | +16% | +$199M |
|
31
Chegg
CHGG
$159M
| $1.44B | 0.8% | 15,985,840 +249,377 | +2% | +$22.5M |
|
32
NovoCure
NVCR
$1.38B
| $1.43B | 0.8% | 8,261,075 +136,430 | +2% | +$23.6M |
|
33
Carvana
CVNA
$51.4B
| $1.39B | 0.77% | 5,806,161 +114,395 | +2% | +$27.4M |
|
34
Elevance Health
ELV
$71.8B
| $1.27B | 0.71% | 3,951,669 -91,681 | -2% | -$29.4M |
|
35
Salesforce
CRM
$245B
| $1.25B | 0.7% | 5,614,737 +101,177 | +2% | +$22.5M |
|
36
Alnylam Pharmaceuticals
ALNY
$58.5B
| $1.19B | 0.66% | 9,132,422 +240,934 | +3% | +$31.3M |
|
37
Ryanair
RYAAY
$33.7B
| $1.15B | 0.64% | 10,492,639 -189,290 | -2% | -$20.8M |
|
|
ONC
38
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $1.1B | 0.61% | 4,247,827 +2,812,638 | +196% | +$727M |
|
39
KE Holdings
BEKE
$20.8B
| $1.09B | 0.6% | 17,631,431 +2,901,701 | +20% | +$179M |
|
40
Roku
ROKU
$14.2B
| $1.04B | 0.58% | 3,132,766 +649,128 | +26% | +$216M |
|
41
Denali Therapeutics
DNLI
$2.23B
| $1.02B | 0.57% | 12,190,256 +1,363,078 | +13% | +$114M |
|
42
Thermo Fisher Scientific
TMO
$186B
| $1.02B | 0.57% | 2,181,583 -56,300 | -3% | -$26.2M |
|
43
Twilio
TWLO
$16.2B
| $1.01B | 0.56% | 2,992,072 -1,913 | -0.1% | -$648K |
|
|
44
Zillow
Z
$20.4B
| $1.01B | 0.56% | 7,745,166 -3,617,908 | -32% | -$470M |
|
45
Appian
APPN
$2.28B
| $996M | 0.55% | 6,142,402 +242,039 | +4% | +$39.2M |
|
|
ABMD
46
DELISTED
Abiomed Inc
ABMD
| $986M | 0.55% | 3,041,827 +96,574 | +3% | +$31.3M |
|
47
Arthur J. Gallagher & Co
AJG
$77.6B
| $985M | 0.55% | 7,962,276 -215,131 | -3% | -$26.6M |
|
48
TSMC
TSM
$1.2T
| $974M | 0.54% | 8,931,444 -746,675 | -8% | -$81.4M |
|
49
Teradyne
TER
$18.8B
| $948M | 0.53% | 7,906,303 -166,002 | -2% | -$19.9M |
|
50
MarketAxess Holdings
MKTX
$6.87B
| $909M | 0.51% | 1,593,978 +16,426 | +1% | +$9.37M |
|